Company Filing History:
2 out of 8 
1 out of 321 
1 out of 238 
Years Active: 2021
Title: The Innovative Contributions of Joong-heui Cho in Pharmaceutical Development
Introduction: Joong-heui Cho, an accomplished inventor based in Daegu, South Korea, has made significant strides in the field of pharmaceutical innovations. With a total of two patents to his name, he is recognized for his work on compounds that have the potential to revolutionize the treatment of protein kinase-related diseases. His inventions exemplify the intersection of chemistry and medicine, highlighting the importance of innovative approaches in healthcare.
Latest Patents: Cho's two latest patents describe new pyrrolo-pyrimidine and pyrrolo-pyridine derivative compounds. The first patent focuses on a pyrrolo-pyrimidine derivative compound, detailing its preparation method and its role as an effective ingredient in pharmaceutical compositions aimed at preventing or treating diseases related to protein kinases. This compound has shown outstanding inhibitory activity against the LRRK2 kinase and has been verified for its effectiveness against various protein kinases, making it a promising candidate for treating conditions such as brain tumors.
The second patent centers on a pyrrolo-pyridine derivative compound, which also presents a method for its preparation and outlines its utility in pharmaceutical compositions for similar protein kinase-related diseases. Notably, the compound has demonstrated excellent inhibitory effects against kinases like DYRK1A, thus holding potential for treating Alzheimer's disease and other related neurodegenerative conditions.
Career Highlights: Joong-heui Cho has worked with reputable institutions such as the Daegu-Gyeongbuk Medical Innovation Foundation and the National Cancer Center. His experience in these organizations has contributed to his understanding of both the scientific and practical aspects of pharmaceutical research and innovation.
Collaborations: Throughout his career, Cho has collaborated with esteemed colleagues, including Hwan Geun Choi and Eunhwa Ko. These partnerships have fostered a productive research environment, enabling the development of compounds that could lead to breakthrough treatments in medicine.
Conclusion: Joong-heui Cho's work exemplifies the essence of innovation within the pharmaceutical field. His patents not only demonstrate technical ingenuity but also the potential to offer significant therapeutic benefits for patients suffering from protein kinase-related diseases. As research continues to evolve, Cho's contributions will undoubtedly play a pivotal role in advancing medical science and improving patient outcomes.